Prostate Cancer Screening - A Perspective on the Current State of the Evidence

N Engl J Med. 2017 Mar 30;376(13):1285-1289. doi: 10.1056/NEJMsb1616281.

Authors

Paul F Pinsky¹, Philip C Prorok¹, Barnett S Kramer¹

Affiliation

¹ From the Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD.

PMID: 28355509
DOI: 10.1056/NEJMsb1616281

No abstract available

MeSH terms

Decision Making
Early Detection of Cancer* / standards
Humans
Male
Mass Screening / standards
Organizational Policy
Practice Guidelines as Topic*
Prostate-Specific Antigen / blood*
Prostatectomy / adverse effects
Prostatic Neoplasms / diagnosis*
Prostatic Neoplasms / therapy
Radiotherapy / adverse effects
Randomized Controlled Trials as Topic
Societies, Medical
United States

Substances

Prostate-Specific Antigen